Hyperion DeFi Inc

Hyperion DeFi Inc (HDF) faces steep volatility and negative earnings. Explore the latest stock performance, airdrop news, and investor cautions for a clear picture of its risky future.

Hyperion DeFi Inc. is pioneering eye‑disease treatments—from glaucoma to dry eye—while navigating biotech volatility, aiming to deliver innovative ophthalmology therapies that improve patient outcomes.